News

Green nail syndrome (GN) is a rare condition often caused by Pseudomonas aeruginosa, typically affecting individuals with damaged nails, psoriasis,...

Menlo Park, Calif., December 19, 2024— Oruka Therapeutics (Nasdaq: ORKA), a biotechnology company focused on innovative biologics for chronic skin...

A new treatment for chronic inducible urticaria (CindU), briquilimab, has shown encouraging results in early-stage clinical trials, with many patients...

A new study sheds light on the complex relationship between comorbidities, social determinants of health, and hidradenitis suppurativa (HS), a...

Australia’s cities are getting hotter, and efforts to reduce urban heat may unintentionally raise the risk of skin cancer, experts...

As 2025 approaches, dermatologists are urging people to leave behind questionable skincare trends in favor of a simple, science-backed routine...

As the holiday season approaches, many young people are eyeing skin care products as potential gifts. But experts caution parents...

A new study has demonstrated that ABP 654, a biosimilar to the reference drug ustekinumab, is equally effective and safe...

Delayed diagnosis of psoriatic arthritis (PsA) remains a significant challenge, often leading to worse functional outcomes for patients, according to...

AbbVie has announced a strategic acquisition of Nimble Therapeutics, a biotech company spun out from Roche, in a deal valued...